Igor A Harsch

Summary

Affiliation: University of Erlangen-Nuremberg
Country: Germany

Publications

  1. ncbi [New trends in therapy of diabetes. More freedom, fewer risks, comfortable insulin administration]
    I A Harsch
    Medizinische Klinik I, Universitat Erlangen Nurnberg
    MMW Fortschr Med 142:24-6. 2000
  2. ncbi The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes
    Igor Alexander Harsch
    1st Department of Medicine, Friedrich Alexander University Erlangen Nurnberg, Erlangen, Germany
    Respiration 71:252-9. 2004
  3. ncbi Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome
    Igor A Harsch
    Department of Medicine I, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    Am J Respir Crit Care Med 169:156-62. 2004
  4. ncbi Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment
    I A Harsch
    Medical Dept 1, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Eur Respir J 22:251-7. 2003
  5. ncbi Resistin levels in patients with obstructive sleep apnoea syndrome--the link to subclinical inflammation?
    Igor Alexander Harsch
    Division of Respiratory Medicine, Medical Department I, Friedrich Alexander University of Erlangen Nuremberg, D 91054 Erlangen, Germany
    Med Sci Monit 10:CR510-5. 2004
  6. ncbi Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance
    I A Harsch
    Medical Department I, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Respiration 71:580-6. 2004
  7. ncbi [Recurrent aspiration, vomiting and coordination disorders. Neurogenic deglutition disorder in Fahr disease. HP-positive gastritis]
    I A Harsch
    Medizinische Klinik I mit Poliklinik, Friedrich Alexander Universitat Erlangen Nurnberg, Krankenhausstrasse 12, 91054 Erlangen
    Internist (Berl) 43:767-70, 772. 2002
  8. ncbi Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome
    Igor Alexander Harsch
    Department of Medicine I, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    Med Sci Monit 11:RA70-5. 2005
  9. ncbi Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens
    I A Harsch
    Department of Medicine I, Division of Endocrinology and Metabolism, Friedrich Alexander University Erlangen Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany
    J Intern Med 252:352-60. 2002
  10. ncbi Inhaled insulins: their potential in the treatment of diabetes mellitus
    Igor Alexander Harsch
    Medical Department of the Friedrich Alexander University Erlangen Nuremberg, Division of Endocrinology and Metabolism, Erlangen, Germany
    Treat Endocrinol 4:131-8. 2005

Collaborators

Detail Information

Publications31

  1. ncbi [New trends in therapy of diabetes. More freedom, fewer risks, comfortable insulin administration]
    I A Harsch
    Medizinische Klinik I, Universitat Erlangen Nurnberg
    MMW Fortschr Med 142:24-6. 2000
    ..The thiazolidinediones, a group of agents that enhance the effects of insulin in target tissue, reduce insulin resistance and improve insulin sensitivity...
  2. ncbi The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes
    Igor Alexander Harsch
    1st Department of Medicine, Friedrich Alexander University Erlangen Nurnberg, Erlangen, Germany
    Respiration 71:252-9. 2004
    ..The obstructive sleep apnoea syndrome (OSA) is a frequent condition, as well as type 2 diabetes mellitus. Both diseases are characterized by insulin resistance...
  3. ncbi Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome
    Igor A Harsch
    Department of Medicine I, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    Am J Respir Crit Care Med 169:156-62. 2004
    ..The effect of CPAP on insulin sensitivity is smaller in obese patients than in nonobese patients, suggesting that in obese individuals insulin sensitivity is mainly determined by obesity and, to a smaller extent, by sleep apnea...
  4. ncbi Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment
    I A Harsch
    Medical Dept 1, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Eur Respir J 22:251-7. 2003
    ..These data indicate that the elevated leptin and ghrelin levels are not determined by obesity alone, since they rapidly decreased during continuous positive airways pressure therapy...
  5. ncbi Resistin levels in patients with obstructive sleep apnoea syndrome--the link to subclinical inflammation?
    Igor Alexander Harsch
    Division of Respiratory Medicine, Medical Department I, Friedrich Alexander University of Erlangen Nuremberg, D 91054 Erlangen, Germany
    Med Sci Monit 10:CR510-5. 2004
    ..The role of resistin, a "new" white adipose tissue hormone, still needs to be established. Its linkage to insulin sensitivity and body mass was controversial in previous studies...
  6. ncbi Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance
    I A Harsch
    Medical Department I, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Respiration 71:580-6. 2004
    ..Adiponectin is an adipocyte-derived hormone with anti-inflammatory and insulin-sensitizing properties. Insulin resistance is a typical feature of the obstructive sleep apnea syndrome (OSAS)...
  7. ncbi [Recurrent aspiration, vomiting and coordination disorders. Neurogenic deglutition disorder in Fahr disease. HP-positive gastritis]
    I A Harsch
    Medizinische Klinik I mit Poliklinik, Friedrich Alexander Universitat Erlangen Nurnberg, Krankenhausstrasse 12, 91054 Erlangen
    Internist (Berl) 43:767-70, 772. 2002
  8. ncbi Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome
    Igor Alexander Harsch
    Department of Medicine I, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    Med Sci Monit 11:RA70-5. 2005
    ....
  9. ncbi Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens
    I A Harsch
    Department of Medicine I, Division of Endocrinology and Metabolism, Friedrich Alexander University Erlangen Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany
    J Intern Med 252:352-60. 2002
    ....
  10. ncbi Inhaled insulins: their potential in the treatment of diabetes mellitus
    Igor Alexander Harsch
    Medical Department of the Friedrich Alexander University Erlangen Nuremberg, Division of Endocrinology and Metabolism, Erlangen, Germany
    Treat Endocrinol 4:131-8. 2005
    ....
  11. ncbi [Unspecified gain of weight?]
    I A Harsch
    Abteilung Endokrinologie und Stoffwechsel, Medizinische Klinik I der Friedrich Alexander Universität Erlangen Nürnberg
    Internist (Berl) 46:1265-9. 2005
    ..The disease is usually reported to be rare, but there is reason enough to assume, that it is frequently misdiagnosed as simple truncal obesity...
  12. ncbi [Respiratory effects of leptin]
    I A Harsch
    Medizinische Klinik I mit Poliklinik der Friedrich Alexander Universität Erlangen Nürnberg, Germany
    Dtsch Med Wochenschr 127:1537-40. 2002
  13. ncbi Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome
    Igor A Harsch
    Department of Medicine I, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    Obes Res 10:625-32. 2002
    ..We were interested in studying whether these conditions are also present in patients with obesity due to LBS with a similar frequency as in patients with "simple" truncal obesity...
  14. ncbi Adiponectin, resistin and subclinical inflammation--the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity
    I A Harsch
    Medical Department I, Division of Endocrinology and Metabolism, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    J Physiol Pharmacol 58:65-76. 2007
    ....
  15. ncbi [Osteoporosis and multiple pregnancy--a case report with positive outcome]
    I A Harsch
    Medizinische Klinik I mit Poliklinik der Friedrich Alexander Universität Erlangen Nürnberg
    Med Klin (Munich) 96:402-7. 2001
    ..Due to the rareness of pregnancy-associated osteoporosis, no guidelines concerning an adequate therapy exist. However, since many antiresorptive drugs are potentially teratogenous, the therapeutic approach is limited...
  16. ncbi [Small intestine diverticulosis -- a rare cause of gastrointestinal bleeding]
    Igor Alexander Harsch
    Medizinische Klinik I mit Poliklinik der Friedrich Alexander Universität Erlangen Nürnberg, Erlangen Nurnberg
    Med Klin (Munich) 99:95-6. 2004
  17. ncbi Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome
    Simin Pour Schahin
    Department of Medicine 1, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    Med Sci Monit 14:CR117-21. 2008
    ..In these very patients we investigated whether this improvement of insulin sensitivity is maintained during long-term CPAP therapy...
  18. ncbi Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines
    Igor A Harsch
    First Department of Medicine I, University Erlangen Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany
    Eur J Pharmacol 481:249-60. 2003
    ....
  19. ncbi Auto-CPAP therapy for obstructive sleep apnea: induction of microarousals by automatic variations of CPAP pressure?
    Florian S Fuchs
    Department of Medicine I, University of Erlangen Nuremberg, Erlangen, Germany
    Sleep 25:514-8. 2002
    ..To investigate the frequency of microarousals (MA) associated with pressure changes during auto-CPAP therapy (APAP) for obstructive sleep apnea (OSA)...
  20. doi Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying
    Igor A Harsch
    Department of Medicine 1, Division of Endocrinology and Metabolism, Friedrich Alexander University Erlangen Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany
    Dig Dis Sci 54:2161-6. 2009
    ..Stable diurnal obestatin levels do not support the concept of interaction between ghrelin and obestatin in terms of regulation of food intake and gastric emptying...
  21. ncbi [Massive ascites of unknown origin. Ovarian tumor]
    Andreas Johannes Naegel
    Medizinische Klinik I, Ulmenweg 18, 91054 Erlangen
    Med Klin (Munich) 100:73-4. 2005
  22. ncbi Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats
    Peter C Konturek
    First Department of Medicine, University Erlangen Nuremberg, Erlangen, Germany
    Eur J Pharmacol 451:191-202. 2002
    ....
  23. ncbi [Diagnosis at a glance. Completely without sports: upper arms like a bodybuilder]
    Igor A Harsch
    Medizinische Klinik I, Chirurgische Universitatsklinik, Friedrich Alexander Universitat Erlangen Nurnberg
    MMW Fortschr Med 147:61. 2005
  24. ncbi [Chronic cough in muscular dystrophy]
    Florian S Fuchs
    Medizinische Klinik I mit Poliklinik, Friedrich Alexander Universitat Erlangen Nurnberg
    Med Klin (Munich) 97:556-7. 2002
  25. ncbi Immunoglobulin E production in chronic pancreatitis
    Martin Raithel
    Functional Tissue Diagnostics, Department of Medicine I, University Erlangen Nuremberg, Germany
    Eur J Gastroenterol Hepatol 15:801-7. 2003
    ..Serum immunoglobulin E (IgE) was investigated in patients with chronic pancreatitis in order to elucidate possible disease mechanisms linking pancreatitis, adverse reaction to foods and allergy...
  26. pmc Metastatic insulinoma - prolonged survival after multimodal approach
    Alexander F Hagel
    Department of Medicine 1, University of Erlangen Nuremberg, Erlangen, Germany
    Med Sci Monit 17:CS103-107. 2011
    ..Metastatic insulinoma is a disease associated with a poor life expectancy...
  27. doi Cortisone replacement therapy in endocrine disorders - quality of self-care
    Igor A Harsch
    Department of Medicine, Division of Endocrinology and Metabolism, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    J Eval Clin Pract 16:492-8. 2010
    ..It is unknown where the patients mainly get their information from and what their preferences in learning about the disease are, as well as what their ideas are on how to improve the knowledge transfer...
  28. ncbi Launois-Bensaude syndrome in a female with type 2 diabetes
    Igor Alexander Harsch
    Department of Medicine I, Friedrich Alexander University, Erlangen Nuremberg, Erlangen, Germany
    Med Sci Monit 9:CS5-8. 2003
    ..Due to the massive accumulation of adipose tissue, the patients frequently have features of the metabolic syndrome as hypertension, impaired fasting glucose or diabetes mellitus, hyperuricemia or hyperlipidemia...
  29. ncbi Left-sided chest pain as an unusual presentation of extrapyramidal symptoms
    Axel Ropohl
    Gen Hosp Psychiatry 27:145-6. 2005
  30. ncbi [Elderly man with movement and bone pain. Only degenerative arthritis manifestations?]
    Igor Alexander Harsch
    Medizinische Klinik 1, Poliklinik der Friedrich Alexander Universität Erlangen Nürnberg
    MMW Fortschr Med 144:41-2. 2002
  31. ncbi [The basic disease had already been diagnosed. Abdominal pain increased]
    Igor Alexander Harsch
    Medizinische Klinik I mit Poliklinik der Universität Erlangen Nürnberg, Krankenhausstrasse 12, D 91054 Erlangen
    MMW Fortschr Med 144:42-4. 2002